Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MDLZ vs MRNA✓SelectedUSD · MRNAMDLZ vs MRNA performance historyLatest closeAs of0.00%11/16
Stock and ETF performance explorer

MDLZ vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+88.5%
MRNA return
+878.5%
Excess return
-790.0%
Maximum drawdown
-29.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D0.0%-3.6%+3.6%+0.1%
7D+1.7%-20.0%+21.6%+2.0%
30D+5.7%-1.3%+6.9%+5.6%
3M+7.1%+240.0%-232.9%+2.9%
6M+13.7%+339.0%-325.3%+8.3%
YTD+28.7%+630.0%-601.2%+20.5%
1Y+23.0%+769.1%-746.1%+14.4%
3Y+4.6%+181.2%-176.6%-0.7%
5Y+23.8%-8.1%+31.9%+19.2%
All+88.5%+878.5%-790.0%+63.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling